These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38057686)

  • 21. Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients.
    Lin PH; Chen SC; Tseng LM; Chang KJ; Huang AC; Cheng KC; Yang K; Wu HC; Chao TY; Chang YC; Lin PC; Kuo WH; Kuo WL; Lin CH; Chen HM; Yeh DC; Liu LC; Liu CY; Wang MY; Lo C; Lu YS; Huang CS
    Breast Cancer Res Treat; 2022 Apr; 192(3):629-637. PubMed ID: 35113257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer.
    Danzinger S; Tan YY; Rudas M; Kastner MT; Weingartshofer S; Muhr D; Singer CF
    BMC Cancer; 2019 Jul; 19(1):695. PubMed ID: 31307407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of women with BRCA mutation.
    Depypere H
    Climacteric; 2023 Jun; 26(3):235-239. PubMed ID: 37011662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
    Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
    JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling.
    Melki R; Melloul M; Aissaoui S; El Harroudi T; Boukhatem N
    BMC Cancer; 2023 Apr; 23(1):339. PubMed ID: 37055759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.
    van der Groep P; van Diest PJ; Smolders YH; Ausems MG; van der Luijt RB; Menko FH; Bart J; de Vries EG; van der Wall E
    PLoS One; 2013; 8(2):e56055. PubMed ID: 23409121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical Evaluation of BAP1 Expression in Breast Cancer with Known
    Çalım-Gürbüz B; Güvendir İ; Ünal B; Erdoğan-Durmuş Ş; Topal CS; Ağaoğlu NB; Doğanay HL; Kızılboğa T; Zemheri IE
    Int J Surg Pathol; 2022 Jun; 30(4):397-404. PubMed ID: 35261270
    [No Abstract]   [Full Text] [Related]  

  • 29. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Graeser MK; Engel C; Rhiem K; Gadzicki D; Bick U; Kast K; Froster UG; Schlehe B; Bechtold A; Arnold N; Preisler-Adams S; Nestle-Kraemling C; Zaino M; Loeffler M; Kiechle M; Meindl A; Varga D; Schmutzler RK
    J Clin Oncol; 2009 Dec; 27(35):5887-92. PubMed ID: 19858402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients.
    Rogozińska-Szczepka J; Utracka-Hutka B; Grzybowska E; Maka B; Nowicka E; Smok-Ragankiewicz A; Zientek H; Steffen J; Wojciechowska-Łacka A
    Ann Oncol; 2004 Sep; 15(9):1373-6. PubMed ID: 15319244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.
    Riahi A; Ghourabi ME; Fourati A; Chaabouni-Bouhamed H
    Breast Cancer; 2017 Mar; 24(2):238-244. PubMed ID: 27025497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families.
    Eerola H; Heinonen M; Heikkilä P; Kilpivaara O; Tamminen A; Aittomäki K; Blomqvist C; Ristimäki A; Nevanlinna H
    Breast Cancer Res; 2008; 10(1):R17. PubMed ID: 18275599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea.
    Ryu JM; Choi HJ; Kim I; Nam SJ; Kim SW; Yu J; Lee SK; Choi DH; Park YH; Kim JW; Seo JS; Park JH; Lee JE; Kim SW;
    Breast Cancer Res Treat; 2019 Jan; 173(2):385-395. PubMed ID: 30350268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive Proteomic Profiling-derived Immunohistochemistry-based Prediction Models for BRCA1 and BRCA2 Germline Mutation-related Breast Carcinomas.
    Vos S; Elias SG; van der Groep P; Smolders YH; van Gils CH; van Diest PJ
    Am J Surg Pathol; 2018 Sep; 42(9):1262-1272. PubMed ID: 29979200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients.
    Mullooly M; Yang HP; Falk RT; Nyante SJ; Cora R; Pfeiffer RM; Radisky DC; Visscher DW; Hartmann LC; Carter JM; Degnim AC; Stanczyk FZ; Figueroa JD; Garcia-Closas M; Lissowska J; Troester MA; Hewitt SM; Brinton LA; Sherman ME; Gierach GL
    Breast Cancer Res; 2017 Jan; 19(1):8. PubMed ID: 28103902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers.
    Ikejima K; Tokioka S; Yagishita K; Kajiura Y; Kanomata N; Yamauchi H; Kurihara Y; Tsunoda H
    J Med Ultrason (2001); 2023 Apr; 50(2):213-220. PubMed ID: 36905492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking and physical inactivity increase cancer prevalence in BRCA-1 and BRCA-2 mutation carriers: results from a retrospective observational analysis.
    Grill S; Yahiaoui-Doktor M; Dukatz R; Lammert J; Ullrich M; Engel C; Pfeifer K; Basrai M; Siniatchkin M; Schmidt T; Weisser B; Rhiem K; Ditsch N; Schmutzler R; Bischoff SC; Halle M; Kiechle M
    Arch Gynecol Obstet; 2017 Dec; 296(6):1135-1144. PubMed ID: 28975393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
    Li A; Xie R; Zhi Q; Deng Y; Wu Y; Li W; Yang L; Jiao Z; Luo J; Zi Y; Sun G; Zhang J; Shi Y; Liu J
    Gynecol Oncol; 2018 Oct; 151(1):145-152. PubMed ID: 30078507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.
    Deb S; Jene N; ; Fox SB
    BMC Cancer; 2012 Nov; 12():510. PubMed ID: 23146383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.